Faridnia Roghiyeh, Daryani Ahmad, Sarvi Shahabeddin, Sharif Mehdi, Kalani Hamed
Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Comp Immunol Microbiol Infect Dis. 2018 Aug;59:32-40. doi: 10.1016/j.cimid.2018.09.005. Epub 2018 Sep 14.
Toxoplasma gondii is an obligate intracellular parasitic protozoan that infects a wide variety of vertebrates as intermediate hosts. The aim of the current systematic review study is to clarify the latest status of studies in the literature regarding rhoptry-associated recombinant proteins or rhoptry-associated recombinant DNAs as potential vaccines against toxoplasmosis. The search was performed systematically in 8 databases, four in English and four in Persian, up to February 2017. Overall, ROP2 was the most commonly used ROPs in DNA vaccines (27.27%) and protein vaccines (6.81%). Furthermore, regarding the type of adjuvants, route and dose of vaccination, animal models, challenge methods, and measurement of immune responses has been discussed in the text. It is hoped that this article help researchers to conduct more effective studies in the field of immunization against T. gondii.
刚地弓形虫是一种专性细胞内寄生原生动物,可感染多种脊椎动物作为中间宿主。当前这项系统评价研究的目的是阐明文献中关于棒状体相关重组蛋白或棒状体相关重组DNA作为抗弓形虫潜在疫苗的研究最新状况。截至2017年2月,系统检索了8个数据库,其中4个英文数据库和4个波斯文数据库。总体而言,ROP2是DNA疫苗(27.27%)和蛋白质疫苗(6.81%)中最常用的棒状体蛋白。此外,文中还讨论了佐剂类型、疫苗接种途径和剂量、动物模型、攻毒方法以及免疫反应的测量。希望本文能帮助研究人员在抗刚地弓形虫免疫领域开展更有效的研究。